Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

‘Microsoft protests Amazon’s $10 billion government cloud computing contract’ -Earlier Engadget Article

https://www.engadget.com/microsoft-amazon-nsa-contract-complaint-094832940.html?src=rss

byBenzinga Newsdesk

August 11, 2021

1 minute read

https://www.engadget.com/microsoft-amazon-nsa-contract-complaint-094832940.html?src=rss

Geron Corporation Announces $175M Proposed Public Offering Of Common Stock

By Michael Horton

Today, 4:50 AM

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced that it intends to offer and sell $175 million of shares of its common stock in an underwritten public offering.

GERN

Eli Lilly Raised FY23 Adjusted EPS Outlook from $8.10-$8.30 To $8.35 to $8.55 Versus Consensus of $8.28

By Benzinga Newsdesk

Today, 4:50 AM

The company reaffirms 2023 sales guidance at $30.3-$30.8 billion compared to the consensus of $30.55 billion

LLY

Wedbush Maintains Neutral on Biogen, Lowers Price Target to $195

By Benzinga Newsdesk

Today, 4:50 AM

Wedbush analyst Laura Chico maintains Biogen (NASDAQ:BIIB) with a Neutral and lowers the price target from $249 to $195.

BIIB

Mirati Therapeutics COO, CMO Exit, Completing Management Overhaul

By Shanthi Rexaline

Today, 4:50 AM

Shares of Mirati Therapeutics, Inc. (NASDAQ: MRTX) are retreating sharply Monday following two executive departures.

AMGN

‘Microsoft protests Amazon’s $10 billion government cloud computing contract’ -Earlier Engadget Article

Related Posts

Geron Corporation Announces $175M Proposed Public Offering Of Common Stock

Eli Lilly Raised FY23 Adjusted EPS Outlook from $8.10-$8.30 To $8.35 to $8.55 Versus Consensus of $8.28

Wedbush Maintains Neutral on Biogen, Lowers Price Target to $195

Mirati Therapeutics COO, CMO Exit, Completing Management Overhaul